{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:25:33Z","timestamp":1761157533320,"version":"3.37.3"},"reference-count":87,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Evaluation Clinical Practice"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Rationale<\/jats:title><jats:p>The 2007 article \u2018Why buprenorphine is so successful in treating opiate addiction in France\u2019\u00a0has been widely cited to promote various solutions to growing opioid\u2010related harms across multiple jurisdictions globally. However, selective promotion of aspects of the French experience or promotion of the French experience without considering relevant contextual factors may inform policies that will not bring the same outcomes as in France, including the introduction of possible unintended negative consequences. The scientific literature is one important arena in which policy solutions are identified, evaluated, promoted\u00a0and disseminated. Scientific communication of the French opioid use disorder care model offers a timely and relevant example through which to examine how problem representations travel and to consider the effects of these representations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims and Objectives<\/jats:title><jats:p>We aimed to explore where, when, and how the content of this 2007 index article has travelled through the scientific literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Informed by Bacchi's understanding of problem representation, we conducted a scientometric analysis of the index article. This included categorical analyses using a combination of citation metadata and content data to identify patterns across locations and time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Researchers in the United States and Anglophone countries affirmatively cited specific index study content, namely less stringent regulations and positive outcomes, such as reductions in overdose deaths and increases in buprenorphine utilization. These citations were more common after 2015 and were more likely to be in discussion sections of nonempirical publications. Researchers from France cited similar content but did so nonaffirmatively, and throughout the study period. Likewise, the French citations were mostly agenda\u2010setting citations in the introductory sections of empirical studies. US studies received the highest attention based on number of citations and Altmetric scores.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>US studies, by focusing on less stringent buprenorphine regulation as the primary solution of concern, have constructed opioid\u2010related harms as a problem of restrictive regulations for buprenorphine. This selective focus on regulation, as opposed to other aspects of the French Model elucidated in the index article such as changes pertaining to the values and financing that structure health service delivery, represents an important missed opportunity for evidence\u2010informed policy learning across jurisdictions.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jep.13822","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T11:07:08Z","timestamp":1684408028000},"page":"576-590","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["How policy problems and solutions travel in the scientific literature: An international scientometric analysis of the French Model of opioid use disorder care"],"prefix":"10.1111","volume":"29","author":[{"given":"Kasunka","family":"Kankanam Gamage","sequence":"first","affiliation":[{"name":"Bridgepoint Collaboratory Lunenfeld\u2010Tanenbaum Research Institute, Sinai Health System  Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellia","family":"Chiu","sequence":"additional","affiliation":[{"name":"Bridgepoint Collaboratory Lunenfeld\u2010Tanenbaum Research Institute, Sinai Health System  Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Ryk","sequence":"additional","affiliation":[{"name":"Bridgepoint Collaboratory Lunenfeld\u2010Tanenbaum Research Institute, Sinai Health System  Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quinn","family":"Grundy","sequence":"additional","affiliation":[{"name":"Lawrence S. Bloomberg Faculty of Nursing University of Toronto  Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8354-6153","authenticated-orcid":false,"given":"Abhimanyu","family":"Sud","sequence":"additional","affiliation":[{"name":"Bridgepoint Collaboratory Lunenfeld\u2010Tanenbaum Research Institute, Sinai Health System  Toronto Ontario Canada"},{"name":"Department of Family and Community Medicine, Temerty Faculty of Medicine University of Toronto  Toronto Ontario Canada"},{"name":"Humber River Hospital  Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.02.001"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170958"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15087"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2019.1635454"},{"key":"e_1_2_8_6_1","unstructured":"World Health Organization. World Health Organization model list of essential medicines 21st List.2019.https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325771\/WHO-MVP-EMP-IAU-2019.06-eng.pdf"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n784"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1089\/pop.2018.0163"},{"issue":"3","key":"e_1_2_8_9_1","first-page":"281","article-title":"Buprenorphine: new treatment of opioid addiction in primary care","volume":"57","author":"Kahan M","year":"2011","journal-title":"Can Fam Physician"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2149"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186315"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-007-0046-2"},{"issue":"4","key":"e_1_2_8_13_1","first-page":"78","article-title":"Opioid* substitution treatment (OST): a French\/Portuguese lesson for Norway and others","volume":"2","author":"Haraldsen M","year":"2017","journal-title":"J Reward Defic Syndr Addict Sci"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.3685"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0958"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa064"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51095"},{"volume-title":"Lesson\u2010Drawing in Public Policy: A Guide to Learning across Time and Space","year":"1993","author":"Rose R","key":"e_1_2_8_18_1"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.13-5-487"},{"issue":"8","key":"e_1_2_8_20_1","first-page":"1373","article-title":"Stakeholder perspectives of attributes and features of context relevant to knowledge translation in health settings: a multi\u2010country analysis","volume":"11","author":"Squires JE","year":"2021","journal-title":"Int J Health Policy Manag"},{"volume-title":"Mirror, Mirror 2021: Reflecting Poorly","year":"2021","author":"Schneider EC","key":"e_1_2_8_21_1"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hpm.2458"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14730"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.5195\/HCS.2012.71"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00949-3"},{"volume-title":"Analysing Policy: What's the Problem Represented to Be?","year":"2009","author":"Bacchi C","key":"e_1_2_8_26_1"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.4236\/ojps.2012.21001"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1057\/978-1-137-52546-8"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-311X2006001300002"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.36.8.837"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.2307\/3109916"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1057\/s41599-019-0232-y"},{"key":"e_1_2_8_33_1","doi-asserted-by":"crossref","unstructured":"P\u00e1lssonG RabinowP. The Iceland: reflections on the transnational market of civic virtue. In:OngA CollierSJ eds.Global assemblages: Technology politics and ethics as anthropological problems.Blackwell;2006:91\u2010104.https:\/\/onlinelibrary.wiley.com\/doi\/book\/10.1002\/9780470696569","DOI":"10.1002\/9780470696569.ch6"},{"key":"e_1_2_8_34_1","unstructured":"LeydesdorffL Milojevi\u0107S.\u00a0Scientometrics.arXivpreprint arXiv: 1208.4566.2012.http:\/\/arxiv.org\/abs\/1208.4566"},{"key":"e_1_2_8_35_1","unstructured":"DimensionsAI.Dimensions. Accessed July 18 2022.https:\/\/www.dimensions.ai\/"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.5195\/jmla.2019.695"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.29173\/jchla29405"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-021-04154-z"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/jep.13680"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-019-03243-4"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1108\/00220410810844150"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-019-03142-8"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184727"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.5688\/ajpe7846"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251488"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1057\/s41599-021-00891-x"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304677"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6770"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2004.30617.x"},{"key":"e_1_2_8_50_1","unstructured":"Australian and New Zealand standard research classification (ANZSRC). Australian Bureau of Statistics. Published June 30 2020. Accessed August 7 2022.https:\/\/www.abs.gov.au\/statistics\/classifications\/australian-and-new-zealand-standard-research-classification-anzsrc\/latest-release"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01735-0"},{"volume-title":"The Architecture of Policy Transfer","author":"Legrand T","key":"e_1_2_8_52_1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-55821-5"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/01442872.2016.1188912"},{"key":"e_1_2_8_54_1","unstructured":"Understanding the Epidemic. Published February 9 2022. Accessed August 8 2022.https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html"},{"key":"e_1_2_8_55_1","unstructured":"FACT SHEET:President Obama proposes $1.1 billion in new funding to address the prescription opioid abuse and heroin use epidemic. whitehouse.gov. Published February 2 2016. Accessed August 8 2022.https:\/\/obamawhitehouse.archives.gov\/the-press-office\/2016\/02\/02\/president-obama-proposes-11-billion-new-funding-address-prescription"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.105771"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.2196\/17693"},{"key":"e_1_2_8_58_1","unstructured":"NIH funds $945 million in research to tackle the national opioid crisis through NIH HEAL Initiative. National Institutes of Health (NIH). Published September 25 2019. Accessed August 9 2022.https:\/\/www.nih.gov\/news-events\/news-releases\/nih-funds-945-million-research-tackle-national-opioid-crisis-through-nih-heal-initiative"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/padr.12228"},{"key":"e_1_2_8_60_1","unstructured":"Opioid harm in Australia: and comparisons between Australia and Canada. Australian Institute of Health and Welfare. Accessed August 24 2022.https:\/\/www.aihw.gov.au\/reports\/illicit-use-of-drugs\/opioid-harm-in-australia\/summary"},{"key":"e_1_2_8_61_1","unstructured":"United Kingdom Country Drug Report 2019. Accessed August 24 2022.https:\/\/www.emcdda.europa.eu\/publications\/country-drug-reports\/2019\/united-kingdom_en"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15826"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1728"},{"key":"e_1_2_8_64_1","unstructured":"France country drug report 2019. Accessed August 16 2022.https:\/\/www.emcdda.europa.eu\/publications\/country-drug-reports\/2019\/france_en"},{"key":"e_1_2_8_65_1","unstructured":"National report 2011: France. Accessed August 16 2022.https:\/\/www.emcdda.europa.eu\/html.cfm\/index191712EN.html_en"},{"key":"e_1_2_8_66_1","unstructured":"National report 2014: France. Accessed August 16 2022.https:\/\/www.emcdda.europa.eu\/publications\/national-reports\/france-2014_en"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1159\/000506630"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-044433"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-020-02217-4"},{"key":"e_1_2_8_70_1","unstructured":"Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe: challenges and implications. Accessed September 13 2022.https:\/\/www.emcdda.europa.eu\/publications\/technical-reports\/opioid-substitution-treatment-ost-in-europe-availability-and-diversion_en"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v16i4.24"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69056-9"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/PRA.0000000000000154"},{"issue":"2","key":"e_1_2_8_74_1","article-title":"The most widely disseminated COVID\u201019\u2010Related scientific publications in online media: a bibliometric analysis of the top 100 articles with the highest Altmetric attention scores","volume":"9","author":"Moon JY","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2012208118"},{"key":"e_1_2_8_76_1","unstructured":"USA's highly\u2010cited researchers power ahead. Accessed August 9 2022.https:\/\/www.researchinformation.info\/news\/usas-highly-cited-researchers-power-ahead"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13280-016-0820-7"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1177\/14550725221102227"},{"key":"e_1_2_8_79_1","unstructured":"DanellR. Geographical diversity and changing communication regimes: a study of publication activity and international citation patterns. Published online 2013.http:\/\/urn.kb.se\/resolve?urn=urn:nbn:se:umu:diva-80105"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.930101204"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00104.x"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-007-0109-5"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-014-0332-6"},{"volume-title":"Medications for Opioid Use Disorder Save Lives","year":"2019","author":"Mancher M","key":"e_1_2_8_84_1"},{"key":"e_1_2_8_85_1","first-page":"796","volume-title":"The Oxford Handbook of Public Health Ethics","author":"Smith M","year":"2019"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103749"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.20738"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-059561"}],"container-title":["Journal of Evaluation in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jep.13822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T17:37:21Z","timestamp":1692466641000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jep.13822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1111\/jep.13822"],"URL":"https:\/\/doi.org\/10.1111\/jep.13822","archive":["Portico"],"relation":{},"ISSN":["1356-1294","1365-2753"],"issn-type":[{"type":"print","value":"1356-1294"},{"type":"electronic","value":"1365-2753"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"assertion":[{"value":"2022-11-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}